“Human Papilloma Virus Immunization Is Cost Effective If Immunity Is Life-Long, and If All 12-Year Old Girls Are Immunized (in the USA)”. Portuguese Journal of Family Medicine and General Practice, vol. 24, no. 5, Sept. 2008, pp. 641-2, https://doi.org/10.32385/rpmgf.v24i5.10555.